2026 NPPES data Pharmacotherapy Pharmacist NPI 1962594523 PHARMD, CDE
Verify on CMS →

TERESA PETRILLA, PHARMD, CDE

Pharmacotherapy Pharmacist in FAIRFIELD, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
254
Medicare Part D claims · 65 beneficiaries · Pharmacotherapy Pharmacist avg: 397
Generic prescribing
26%
generic claims · 74% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

TERESA PETRILLA, PHARMD, CDE filed 254 Medicare Part D claims in 2023 as a Pharmacotherapy Pharmacist in FAIRFIELD, California, prescribing 26% generic.

254
Part D claims, 2023
26%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

TERESA PETRILLA, PHARMD, CDE's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

254 49th percentile higher than 49% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about TERESA PETRILLA, PHARMD, CDE?

Quality data not reported

NPI registry status

Active

Issued 09/29/2006

NPI 1962594523

Primary specialty

Pharmacotherapy Pharmacist

Mid-sized

5,925 US NPIs in this specialty

Medicare Part D claims

254 36% vs specialty avg

2023 prescription claims

Specialty avg: 397

Specialty distribution in California

How Pharmacotherapy Pharmacist compares to other specialties among California providers

California providers

Pharmacotherapy Pharmacist share within California

1. Pharmacotherapy Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacotherapy Pharmacist share within California

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacotherapy Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacotherapy Pharmacist ABMS/AOA estimate

Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

TERESA PETRILLA, PHARMD, CDE appears in the CMS NPPES registry as a Pharmacotherapy Pharmacist provider holding PHARMD, CDE credentials at 1550 GATEWAY BLVD, FAIRFIELD, CA, 94533, with a listed phone of (707) 427-4425. NPI 1962594523 was issued on 09/29/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PETRILLA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 254 prescription claims written by this provider, covering 65 Medicare beneficiaries and totaling roughly $82K in drug spend, split 74% brand-name and 26% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacotherapy Pharmacist is a mid-sized specialty nationwide, with 5,925 enrolled providers across 53 states and an average of 397 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1550 GATEWAY BLVD
FAIRFIELD, CA 94533

Provider Details

NPI 1962594523
Specialty Pharmacotherapy Pharmacist
Credentials PHARMD, CDE
Gender Female
NPI Issued 09/29/2006

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to TERESA PETRILLA, PHARMD, CDE. To verify TERESA PETRILLA, PHARMD, CDE's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

TERESA PETRILLA, PHARMD, CDE — brand share 74.0%
Specialty average (est.)

74% brand-name claims vs 26% generic, on 254 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

254
Total Claims
$82K
Total Drug Cost
65
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
700
Total Day Supply
20,926
Brand vs Generic
74% brand / 26% generic
Brand Drug Cost
$69K
Generic Drug Cost
$627

Patient Demographics

Average Patient Age
67.2 years
Avg HCC Risk Score
1.60
Gender Split
46% female / 54% male
Age Distribution
<65: 14, 65-74: 38, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What TERESA PETRILLA, PHARMD, CDE prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Humalog
Insulin Lispro
83
Insulin Glargine-Yfgn
29
Atorvastatin Calcium
24
Humalog Kwikpen U-100
Insulin Lispro
23
Lantus
"Insulin Glargine
N/A
Veo Insulin Syringe
"Syrge-Ndl
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacotherapy Pharmacist Overview

How TERESA PETRILLA, PHARMD, CDE fits within the Pharmacotherapy Pharmacist landscape nationally.

5,925
Pharmacotherapy Pharmacist Providers in US
53
States with Pharmacotherapy Pharmacist
397
Avg Claims per Provider

TERESA PETRILLA, PHARMD, CDE's 254 claims are below the specialty average of 397.

Nearby Pharmacotherapy Pharmacist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as PETRILLA.

Compare Pharmacotherapy Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is TERESA PETRILLA, PHARMD, CDE's specialty?
TERESA PETRILLA, PHARMD, CDE specializes in Pharmacotherapy Pharmacist and practices in FAIRFIELD, California. Credentials: PHARMD, CDE.
How much does TERESA PETRILLA, PHARMD, CDE prescribe under Medicare Part D?
In 2023, TERESA PETRILLA, PHARMD, CDE wrote 254 Medicare Part D claims totaling $82K in drug costs for 65 beneficiaries.
Where is TERESA PETRILLA, PHARMD, CDE located?
TERESA PETRILLA, PHARMD, CDE is located at 1550 GATEWAY BLVD, FAIRFIELD, CA, 94533. Phone: (707) 427-4425.
What is TERESA PETRILLA, PHARMD, CDE's NPI number?
TERESA PETRILLA, PHARMD, CDE's National Provider Identifier (NPI) is 1962594523, issued on 09/29/2006.
Does TERESA PETRILLA, PHARMD, CDE prescribe more brand-name or generic drugs?
TERESA PETRILLA, PHARMD, CDE's prescribing is 74% brand-name and 26% generic drugs by claim count, with $69K in brand drug costs.
How many Pharmacotherapy Pharmacist providers are there in the US?
There are 5,925 Pharmacotherapy Pharmacist providers across 53 states in the US. The average Pharmacotherapy Pharmacist provider writes 397 Medicare Part D claims per year.
What drugs does TERESA PETRILLA, PHARMD, CDE prescribe most often?
Based on 2023 Medicare Part D data, TERESA PETRILLA, PHARMD, CDE's most frequently prescribed drugs include Humalog, Insulin Glargine-Yfgn, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does TERESA PETRILLA, PHARMD, CDE accept Medicare?
TERESA PETRILLA, PHARMD, CDE appears in CMS Medicare data with 254 Part D claims and 65 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify TERESA PETRILLA, PHARMD, CDE's credentials?
TERESA PETRILLA, PHARMD, CDE's NPI is 1962594523 with credentials PHARMD, CDE. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology